Drug intelligence / Profile preview

PainBloc24

Development stage
Unknown
Lead developer
Vizuri Health Sciences
Modality
Small Molecules
Administration
Topical
01

Overview

PainBloc24 is an over-the-counter (OTC) topical analgesic developed by Vizuri Health Sciences LLC for the temporary relief of minor aches and pains associated with arthritis, simple backache, muscle strains, bruises, and sprains. The active ingredient is capsaicin at a 0.25% concentration, which is derived from chili peppers. PainBloc24 works by acting as an agonist for the Transient Receptor Potential Vanilloid 1 (TRPV1) receptor on nociceptive nerve fibers. Initial application causes activation of these fibers, but repeated or sustained exposure leads to the desensitization and functional deactivation of the nerve fibers, thereby blocking the transmission of pain signals to the brain. It is marketed as the only OTC topical pain reliever providing up to 24-hour relief with a single daily application and is available in roll-on and patch formulations.

Brand names
PainBloc24PainBloc-24PainBloc 24
Other names
1% capsaicin topical liquid
02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on PainBloc24.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PainBloc24.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call